PLUS vs. SCSC, WSTG, INFA, HCP, PEGA, ACIW, BLKB, SPNS, VRNT, and SWI
Should you be buying ePlus stock or one of its competitors? The main competitors of ePlus include ScanSource (SCSC), Wayside Technology Group (WSTG), Informatica (INFA), HashiCorp (HCP), Pegasystems (PEGA), ACI Worldwide (ACIW), Blackbaud (BLKB), Sapiens International (SPNS), Verint Systems (VRNT), and SolarWinds (SWI).
ScanSource (NASDAQ:SCSC) and ePlus (NASDAQ:PLUS) are both industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.
ePlus has lower revenue, but higher earnings than ScanSource. ScanSource is trading at a lower price-to-earnings ratio than ePlus, indicating that it is currently the more affordable of the two stocks.
ePlus received 29 more outperform votes than ScanSource when rated by MarketBeat users. Likewise, 63.59% of users gave ePlus an outperform vote while only 57.39% of users gave ScanSource an outperform vote.
97.9% of ScanSource shares are held by institutional investors. Comparatively, 93.8% of ePlus shares are held by institutional investors. 4.6% of ScanSource shares are held by insiders. Comparatively, 2.4% of ePlus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
ePlus has a net margin of 5.20% compared to ePlus' net margin of 2.31%. ScanSource's return on equity of 13.47% beat ePlus' return on equity.
In the previous week, ePlus had 3 more articles in the media than ScanSource. MarketBeat recorded 7 mentions for ePlus and 4 mentions for ScanSource. ePlus' average media sentiment score of 1.81 beat ScanSource's score of 1.25 indicating that ScanSource is being referred to more favorably in the media.
ScanSource presently has a consensus target price of $35.50, indicating a potential downside of 29.54%. ePlus has a consensus target price of $86.50, indicating a potential downside of 4.97%. Given ScanSource's higher probable upside, analysts plainly believe ePlus is more favorable than ScanSource.
ScanSource has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, ePlus has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.
Summary
ePlus beats ScanSource on 11 of the 18 factors compared between the two stocks.
Get ePlus News Delivered to You Automatically
Sign up to receive the latest news and ratings for PLUS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PLUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
